U.S. Plegridy Approval; Red Blood Cells to Deliver Drugs; Corruption and Unproven MS Supplement; Anxiety of Multiple Sclerosis

A review of five head-to-head clinical trials suggests that interferon β and glatiramer acetate are clinically similar disease-modifying therapies with some differences in MRI outcomes that clinicians should consider